UConn Professor Asks: Would Reducing Pharmaceutical Sales Calls to Physicians Help, or Harm, Patients?
When a pharmaceutical company sends a representative to your doctor’s office to promote a new or existing medication, is that a benefit to you as a patient? Would restricting those visits bring greater fairness to the pharmaceutical industry—or prevent your doctor from being well-informed about treatment options?Continue Reading